202 related articles for article (PubMed ID: 9706170)
1. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies.
Genden EM; Mackinnon SE; Yu S; Flye MW
Surgery; 1998 Aug; 124(2):448-56. PubMed ID: 9706170
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
[TBL] [Abstract][Full Text] [Related]
3. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
Yu S; Nakafusa Y; Flye MW
Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against ICAM-1 and LFA-1 prolong nerve allograft survival.
Nakao Y; MacKinnon SE; Hertl MC; Miyasaka M; Hunter DA; Mohanakumar T
Muscle Nerve; 1995 Jan; 18(1):93-102. PubMed ID: 7800003
[TBL] [Abstract][Full Text] [Related]
5. Portal venous ultraviolet B-irradiated donor alloantigen prevents rejection in circumferential rat tracheal allografts.
Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
Otolaryngol Head Neck Surg; 2001 May; 124(5):481-8. PubMed ID: 11337649
[TBL] [Abstract][Full Text] [Related]
6. Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506.
Bashuda H; Takazawa K; Tamatani T; Miyasaka M; Yagita H; Okumura K
Transplantation; 1996 Jul; 62(1):117-22. PubMed ID: 8693525
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
8. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection.
Miwa S; Isobe M; Suzuki J; Makuuchi M; Miyasaka M; Yamazaki S; Kawasaki S
Surgery; 1997 Jun; 121(6):681-9. PubMed ID: 9186469
[TBL] [Abstract][Full Text] [Related]
10. Specific acceptance of fetal bowel allograft in mice after combined treatment with anti-intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 antibodies.
Kato Y; Yamataka A; Yagita H; Okumura K; Fujiwara T; Miyano T
Ann Surg; 1996 Jan; 223(1):94-100. PubMed ID: 8554424
[TBL] [Abstract][Full Text] [Related]
11. Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind-limb transplants.
Ozer K; Siemionow M
J Reconstr Microsurg; 2001 Oct; 17(7):511-7; discussion 518. PubMed ID: 11598825
[TBL] [Abstract][Full Text] [Related]
12. Cardiac allografts in rat recipients with simultaneous use of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies leads to accelerated graft loss.
Morikawa M; Tamatani T; Miyasaka M; Uede T
Immunopharmacology; 1994; 28(3):171-82. PubMed ID: 7852048
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effect of monoclonal antibodies to ICAM-1 and LFA-1 on peripheral nerve allograft in mice.
Nakao Y; Mackinnon SE; Strasberg SR; Hertl MC; Isobe M; Susskind BM; Mohanakumar T; Hunter DA
Microsurgery; 1995; 16(9):612-20. PubMed ID: 8747285
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
15. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells.
Yu S; Nakafusa Y; Flye MW
Transplantation; 1997 Dec; 64(12):1684-8. PubMed ID: 9422402
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection.
Iwata T; Kamei Y; Esaki S; Takada T; Torii S; Yamashita A; Tomida S; Tamatani T; Miyasaka M; Yoshikai Y
Immunobiology; 1996 Jul; 195(2):160-71. PubMed ID: 8877393
[TBL] [Abstract][Full Text] [Related]
18. Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection.
Ohta Y; Gotoh M; Ohzato H; Fukuzaki T; Nishihara M; Dono K; Umeshita K; Sakon M; Yagita H; Okumura K; Tanaka T; Kawashima H; Miyasaka M; Monden M
Transplantation; 1998 Apr; 65(8):1094-100. PubMed ID: 9583871
[TBL] [Abstract][Full Text] [Related]
19. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1997 Nov; 16(11):1149-56. PubMed ID: 9402515
[TBL] [Abstract][Full Text] [Related]
20. Treatment with monoclonal antibodies to ICAM-1 and LFA-1 in rat heart allograft rejection.
Brandt M; Steinmann J; Steinhoff G; Haverich A
Transpl Int; 1997; 10(2):141-4. PubMed ID: 9090001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
